Gamma-radiated immunosuppressed tumor xenograft mice can be a new ideal model in cancer research

Tumor xenograft models can create a high capacity to study human tumors and discover efficient therapeutic approaches. Here, we aimed to develop the gamma-radiated immunosuppressed (GIS) mice as a new kind of tumor xenograft model for biomedical studies. First, 144 mice were divided into the control...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scientific reports 2021-01, Vol.11 (1), p.256-256
Hauptverfasser: Khodayari, Hamid, Khodayari, Saeed, Khalighfard, Solmaz, Tahmasebifar, Arash, Tajaldini, Mahboubeh, Poorkhani, Amirhoushang, Nikoueinejad, Hassan, Hamidi, Gholam Ali, Nosrati, Hassan, Kalhori, Mohammad Reza, Alizadeh, Ali Mohammad
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 256
container_issue 1
container_start_page 256
container_title Scientific reports
container_volume 11
creator Khodayari, Hamid
Khodayari, Saeed
Khalighfard, Solmaz
Tahmasebifar, Arash
Tajaldini, Mahboubeh
Poorkhani, Amirhoushang
Nikoueinejad, Hassan
Hamidi, Gholam Ali
Nosrati, Hassan
Kalhori, Mohammad Reza
Alizadeh, Ali Mohammad
description Tumor xenograft models can create a high capacity to study human tumors and discover efficient therapeutic approaches. Here, we aimed to develop the gamma-radiated immunosuppressed (GIS) mice as a new kind of tumor xenograft model for biomedical studies. First, 144 mice were divided into the control and treated groups exposed by a medical Cobalt-60 apparatus in 3, 4, and 5 Gy based on the system outputs. Then, 144 BALB/c mice were divided into four groups; healthy, xenograft, radiation, and radiation + xenograft groups. The animals in the xenograft and radiation + xenograft groups have subcutaneously received 3 × 10 MCF-7 cells 24 h post-radiation. On 3, 7, 14, and 21 days after cell injection, the animals were sacrificed. Then, the blood samples and the spleen and tumor tissues were removed for the cellular and molecular analyses. The whole-body gamma radiation had a high immunosuppressive effect on the BALB/c mice from 1 to 21 days post-radiation. The macroscopic and histopathological observations have proved that the created clusters' tumor structure resulted in the xenograft breast tumor. There was a significant increase in tumor size after cell injection until the end of the study. Except for Treg, the spleen level of CD4, CD8, CD19, and Ly6G was significantly decreased in Xen + Rad compared to the Xen alone group on 3 and 7 days. Unlike IL-4 and IL-10, the spleen level of TGF-β, INF-γ, IL-12, and IL-17 was considerably decreased in the Xen + Rad than the Xen alone group on 3 and 7 days. The spleen expressions of the VEGF, Ki67, and Bax/Bcl-2 ratio were dramatically increased in the Xen + Rad group compared to the Xen alone on 3, 7, 14, and 21 days. Our results could confirm a new tumor xenograft model via an efficient immune-suppressive potential of the whole-body gamma radiation in mice.
doi_str_mv 10.1038/s41598-020-80428-5
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7794493</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2476252912</sourcerecordid><originalsourceid>FETCH-LOGICAL-p294t-4369c064ac4b020e5aeeb8953c752cb0dcdeb55725e9ee6f26d3939a03ec03243</originalsourceid><addsrcrecordid>eNpdUEtLxjAQDIKoqH_AgwS8eKmmebTNRRDRT0Hwoue6TffTSJPUpPXx741P1L0s7MwOM0PITskOSiaawyRLpZuCcVY0TPKmUCtkgzOpCi44XyfbKT2wPIprWeo1si6E5IxX5Qa5XYBzUEToLUzYU-vc7EOaxzFiSvkwzS5E-oI-3EVYTtRZg9SApx1SoB6fqe0RBupCjwO1_h0zGGl-R4jmfousLmFIuP21N8nN2en1yXlxebW4ODm-LMZsaiqkqLRhlQQju5wDFSB2jVbC1IqbjvWmx06pmivUiNWSV73QQgMTaJjgUmySo0_dce4c9gb9FGFox2gdxNc2gG3_It7et3fhqa1rLaUWWWD_SyCGxxnT1DqbDA4DeAxzarmsK1Wxqm4yde8f9SHM0ed4Hyyeey55Zu3-dvRj5bt88QaOjobp</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2476252912</pqid></control><display><type>article</type><title>Gamma-radiated immunosuppressed tumor xenograft mice can be a new ideal model in cancer research</title><source>Nature Open Access</source><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>Springer Nature OA/Free Journals</source><source>Free Full-Text Journals in Chemistry</source><creator>Khodayari, Hamid ; Khodayari, Saeed ; Khalighfard, Solmaz ; Tahmasebifar, Arash ; Tajaldini, Mahboubeh ; Poorkhani, Amirhoushang ; Nikoueinejad, Hassan ; Hamidi, Gholam Ali ; Nosrati, Hassan ; Kalhori, Mohammad Reza ; Alizadeh, Ali Mohammad</creator><creatorcontrib>Khodayari, Hamid ; Khodayari, Saeed ; Khalighfard, Solmaz ; Tahmasebifar, Arash ; Tajaldini, Mahboubeh ; Poorkhani, Amirhoushang ; Nikoueinejad, Hassan ; Hamidi, Gholam Ali ; Nosrati, Hassan ; Kalhori, Mohammad Reza ; Alizadeh, Ali Mohammad</creatorcontrib><description>Tumor xenograft models can create a high capacity to study human tumors and discover efficient therapeutic approaches. Here, we aimed to develop the gamma-radiated immunosuppressed (GIS) mice as a new kind of tumor xenograft model for biomedical studies. First, 144 mice were divided into the control and treated groups exposed by a medical Cobalt-60 apparatus in 3, 4, and 5 Gy based on the system outputs. Then, 144 BALB/c mice were divided into four groups; healthy, xenograft, radiation, and radiation + xenograft groups. The animals in the xenograft and radiation + xenograft groups have subcutaneously received 3 × 10 MCF-7 cells 24 h post-radiation. On 3, 7, 14, and 21 days after cell injection, the animals were sacrificed. Then, the blood samples and the spleen and tumor tissues were removed for the cellular and molecular analyses. The whole-body gamma radiation had a high immunosuppressive effect on the BALB/c mice from 1 to 21 days post-radiation. The macroscopic and histopathological observations have proved that the created clusters' tumor structure resulted in the xenograft breast tumor. There was a significant increase in tumor size after cell injection until the end of the study. Except for Treg, the spleen level of CD4, CD8, CD19, and Ly6G was significantly decreased in Xen + Rad compared to the Xen alone group on 3 and 7 days. Unlike IL-4 and IL-10, the spleen level of TGF-β, INF-γ, IL-12, and IL-17 was considerably decreased in the Xen + Rad than the Xen alone group on 3 and 7 days. The spleen expressions of the VEGF, Ki67, and Bax/Bcl-2 ratio were dramatically increased in the Xen + Rad group compared to the Xen alone on 3, 7, 14, and 21 days. Our results could confirm a new tumor xenograft model via an efficient immune-suppressive potential of the whole-body gamma radiation in mice.</description><identifier>EISSN: 2045-2322</identifier><identifier>DOI: 10.1038/s41598-020-80428-5</identifier><identifier>PMID: 33420261</identifier><language>eng</language><publisher>England: Nature Publishing Group</publisher><subject>Animals ; Antigens, Differentiation - metabolism ; Bcl-2 protein ; Breast cancer ; Breast Neoplasms - pathology ; Cancer research ; CD19 antigen ; CD4 antigen ; CD8 antigen ; Cell size ; Cobalt ; Cobalt Radioisotopes ; Cytokines - genetics ; Cytokines - metabolism ; Disease Models, Animal ; Female ; Gamma Rays ; Heterografts ; Humans ; Immunosuppression ; Immunosuppression Therapy - methods ; Injection ; Interleukin 10 ; Interleukin 12 ; Interleukin 17 ; Interleukin 4 ; Lymphocytes T ; MCF-7 Cells ; Mice ; Mice, Inbred BALB C ; Post-radiation ; Spleen ; Spleen - immunology ; Spleen - metabolism ; Tumor Burden ; Tumors ; Vascular endothelial growth factor ; Xenografts ; γ Radiation</subject><ispartof>Scientific reports, 2021-01, Vol.11 (1), p.256-256</ispartof><rights>The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794493/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794493/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33420261$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Khodayari, Hamid</creatorcontrib><creatorcontrib>Khodayari, Saeed</creatorcontrib><creatorcontrib>Khalighfard, Solmaz</creatorcontrib><creatorcontrib>Tahmasebifar, Arash</creatorcontrib><creatorcontrib>Tajaldini, Mahboubeh</creatorcontrib><creatorcontrib>Poorkhani, Amirhoushang</creatorcontrib><creatorcontrib>Nikoueinejad, Hassan</creatorcontrib><creatorcontrib>Hamidi, Gholam Ali</creatorcontrib><creatorcontrib>Nosrati, Hassan</creatorcontrib><creatorcontrib>Kalhori, Mohammad Reza</creatorcontrib><creatorcontrib>Alizadeh, Ali Mohammad</creatorcontrib><title>Gamma-radiated immunosuppressed tumor xenograft mice can be a new ideal model in cancer research</title><title>Scientific reports</title><addtitle>Sci Rep</addtitle><description>Tumor xenograft models can create a high capacity to study human tumors and discover efficient therapeutic approaches. Here, we aimed to develop the gamma-radiated immunosuppressed (GIS) mice as a new kind of tumor xenograft model for biomedical studies. First, 144 mice were divided into the control and treated groups exposed by a medical Cobalt-60 apparatus in 3, 4, and 5 Gy based on the system outputs. Then, 144 BALB/c mice were divided into four groups; healthy, xenograft, radiation, and radiation + xenograft groups. The animals in the xenograft and radiation + xenograft groups have subcutaneously received 3 × 10 MCF-7 cells 24 h post-radiation. On 3, 7, 14, and 21 days after cell injection, the animals were sacrificed. Then, the blood samples and the spleen and tumor tissues were removed for the cellular and molecular analyses. The whole-body gamma radiation had a high immunosuppressive effect on the BALB/c mice from 1 to 21 days post-radiation. The macroscopic and histopathological observations have proved that the created clusters' tumor structure resulted in the xenograft breast tumor. There was a significant increase in tumor size after cell injection until the end of the study. Except for Treg, the spleen level of CD4, CD8, CD19, and Ly6G was significantly decreased in Xen + Rad compared to the Xen alone group on 3 and 7 days. Unlike IL-4 and IL-10, the spleen level of TGF-β, INF-γ, IL-12, and IL-17 was considerably decreased in the Xen + Rad than the Xen alone group on 3 and 7 days. The spleen expressions of the VEGF, Ki67, and Bax/Bcl-2 ratio were dramatically increased in the Xen + Rad group compared to the Xen alone on 3, 7, 14, and 21 days. Our results could confirm a new tumor xenograft model via an efficient immune-suppressive potential of the whole-body gamma radiation in mice.</description><subject>Animals</subject><subject>Antigens, Differentiation - metabolism</subject><subject>Bcl-2 protein</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - pathology</subject><subject>Cancer research</subject><subject>CD19 antigen</subject><subject>CD4 antigen</subject><subject>CD8 antigen</subject><subject>Cell size</subject><subject>Cobalt</subject><subject>Cobalt Radioisotopes</subject><subject>Cytokines - genetics</subject><subject>Cytokines - metabolism</subject><subject>Disease Models, Animal</subject><subject>Female</subject><subject>Gamma Rays</subject><subject>Heterografts</subject><subject>Humans</subject><subject>Immunosuppression</subject><subject>Immunosuppression Therapy - methods</subject><subject>Injection</subject><subject>Interleukin 10</subject><subject>Interleukin 12</subject><subject>Interleukin 17</subject><subject>Interleukin 4</subject><subject>Lymphocytes T</subject><subject>MCF-7 Cells</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Post-radiation</subject><subject>Spleen</subject><subject>Spleen - immunology</subject><subject>Spleen - metabolism</subject><subject>Tumor Burden</subject><subject>Tumors</subject><subject>Vascular endothelial growth factor</subject><subject>Xenografts</subject><subject>γ Radiation</subject><issn>2045-2322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpdUEtLxjAQDIKoqH_AgwS8eKmmebTNRRDRT0Hwoue6TffTSJPUpPXx741P1L0s7MwOM0PITskOSiaawyRLpZuCcVY0TPKmUCtkgzOpCi44XyfbKT2wPIprWeo1si6E5IxX5Qa5XYBzUEToLUzYU-vc7EOaxzFiSvkwzS5E-oI-3EVYTtRZg9SApx1SoB6fqe0RBupCjwO1_h0zGGl-R4jmfousLmFIuP21N8nN2en1yXlxebW4ODm-LMZsaiqkqLRhlQQju5wDFSB2jVbC1IqbjvWmx06pmivUiNWSV73QQgMTaJjgUmySo0_dce4c9gb9FGFox2gdxNc2gG3_It7et3fhqa1rLaUWWWD_SyCGxxnT1DqbDA4DeAxzarmsK1Wxqm4yde8f9SHM0ed4Hyyeey55Zu3-dvRj5bt88QaOjobp</recordid><startdate>20210108</startdate><enddate>20210108</enddate><creator>Khodayari, Hamid</creator><creator>Khodayari, Saeed</creator><creator>Khalighfard, Solmaz</creator><creator>Tahmasebifar, Arash</creator><creator>Tajaldini, Mahboubeh</creator><creator>Poorkhani, Amirhoushang</creator><creator>Nikoueinejad, Hassan</creator><creator>Hamidi, Gholam Ali</creator><creator>Nosrati, Hassan</creator><creator>Kalhori, Mohammad Reza</creator><creator>Alizadeh, Ali Mohammad</creator><general>Nature Publishing Group</general><general>Nature Publishing Group UK</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210108</creationdate><title>Gamma-radiated immunosuppressed tumor xenograft mice can be a new ideal model in cancer research</title><author>Khodayari, Hamid ; Khodayari, Saeed ; Khalighfard, Solmaz ; Tahmasebifar, Arash ; Tajaldini, Mahboubeh ; Poorkhani, Amirhoushang ; Nikoueinejad, Hassan ; Hamidi, Gholam Ali ; Nosrati, Hassan ; Kalhori, Mohammad Reza ; Alizadeh, Ali Mohammad</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p294t-4369c064ac4b020e5aeeb8953c752cb0dcdeb55725e9ee6f26d3939a03ec03243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Animals</topic><topic>Antigens, Differentiation - metabolism</topic><topic>Bcl-2 protein</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - pathology</topic><topic>Cancer research</topic><topic>CD19 antigen</topic><topic>CD4 antigen</topic><topic>CD8 antigen</topic><topic>Cell size</topic><topic>Cobalt</topic><topic>Cobalt Radioisotopes</topic><topic>Cytokines - genetics</topic><topic>Cytokines - metabolism</topic><topic>Disease Models, Animal</topic><topic>Female</topic><topic>Gamma Rays</topic><topic>Heterografts</topic><topic>Humans</topic><topic>Immunosuppression</topic><topic>Immunosuppression Therapy - methods</topic><topic>Injection</topic><topic>Interleukin 10</topic><topic>Interleukin 12</topic><topic>Interleukin 17</topic><topic>Interleukin 4</topic><topic>Lymphocytes T</topic><topic>MCF-7 Cells</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Post-radiation</topic><topic>Spleen</topic><topic>Spleen - immunology</topic><topic>Spleen - metabolism</topic><topic>Tumor Burden</topic><topic>Tumors</topic><topic>Vascular endothelial growth factor</topic><topic>Xenografts</topic><topic>γ Radiation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Khodayari, Hamid</creatorcontrib><creatorcontrib>Khodayari, Saeed</creatorcontrib><creatorcontrib>Khalighfard, Solmaz</creatorcontrib><creatorcontrib>Tahmasebifar, Arash</creatorcontrib><creatorcontrib>Tajaldini, Mahboubeh</creatorcontrib><creatorcontrib>Poorkhani, Amirhoushang</creatorcontrib><creatorcontrib>Nikoueinejad, Hassan</creatorcontrib><creatorcontrib>Hamidi, Gholam Ali</creatorcontrib><creatorcontrib>Nosrati, Hassan</creatorcontrib><creatorcontrib>Kalhori, Mohammad Reza</creatorcontrib><creatorcontrib>Alizadeh, Ali Mohammad</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Scientific reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Khodayari, Hamid</au><au>Khodayari, Saeed</au><au>Khalighfard, Solmaz</au><au>Tahmasebifar, Arash</au><au>Tajaldini, Mahboubeh</au><au>Poorkhani, Amirhoushang</au><au>Nikoueinejad, Hassan</au><au>Hamidi, Gholam Ali</au><au>Nosrati, Hassan</au><au>Kalhori, Mohammad Reza</au><au>Alizadeh, Ali Mohammad</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gamma-radiated immunosuppressed tumor xenograft mice can be a new ideal model in cancer research</atitle><jtitle>Scientific reports</jtitle><addtitle>Sci Rep</addtitle><date>2021-01-08</date><risdate>2021</risdate><volume>11</volume><issue>1</issue><spage>256</spage><epage>256</epage><pages>256-256</pages><eissn>2045-2322</eissn><abstract>Tumor xenograft models can create a high capacity to study human tumors and discover efficient therapeutic approaches. Here, we aimed to develop the gamma-radiated immunosuppressed (GIS) mice as a new kind of tumor xenograft model for biomedical studies. First, 144 mice were divided into the control and treated groups exposed by a medical Cobalt-60 apparatus in 3, 4, and 5 Gy based on the system outputs. Then, 144 BALB/c mice were divided into four groups; healthy, xenograft, radiation, and radiation + xenograft groups. The animals in the xenograft and radiation + xenograft groups have subcutaneously received 3 × 10 MCF-7 cells 24 h post-radiation. On 3, 7, 14, and 21 days after cell injection, the animals were sacrificed. Then, the blood samples and the spleen and tumor tissues were removed for the cellular and molecular analyses. The whole-body gamma radiation had a high immunosuppressive effect on the BALB/c mice from 1 to 21 days post-radiation. The macroscopic and histopathological observations have proved that the created clusters' tumor structure resulted in the xenograft breast tumor. There was a significant increase in tumor size after cell injection until the end of the study. Except for Treg, the spleen level of CD4, CD8, CD19, and Ly6G was significantly decreased in Xen + Rad compared to the Xen alone group on 3 and 7 days. Unlike IL-4 and IL-10, the spleen level of TGF-β, INF-γ, IL-12, and IL-17 was considerably decreased in the Xen + Rad than the Xen alone group on 3 and 7 days. The spleen expressions of the VEGF, Ki67, and Bax/Bcl-2 ratio were dramatically increased in the Xen + Rad group compared to the Xen alone on 3, 7, 14, and 21 days. Our results could confirm a new tumor xenograft model via an efficient immune-suppressive potential of the whole-body gamma radiation in mice.</abstract><cop>England</cop><pub>Nature Publishing Group</pub><pmid>33420261</pmid><doi>10.1038/s41598-020-80428-5</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier EISSN: 2045-2322
ispartof Scientific reports, 2021-01, Vol.11 (1), p.256-256
issn 2045-2322
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7794493
source Nature Open Access; MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection; Springer Nature OA/Free Journals; Free Full-Text Journals in Chemistry
subjects Animals
Antigens, Differentiation - metabolism
Bcl-2 protein
Breast cancer
Breast Neoplasms - pathology
Cancer research
CD19 antigen
CD4 antigen
CD8 antigen
Cell size
Cobalt
Cobalt Radioisotopes
Cytokines - genetics
Cytokines - metabolism
Disease Models, Animal
Female
Gamma Rays
Heterografts
Humans
Immunosuppression
Immunosuppression Therapy - methods
Injection
Interleukin 10
Interleukin 12
Interleukin 17
Interleukin 4
Lymphocytes T
MCF-7 Cells
Mice
Mice, Inbred BALB C
Post-radiation
Spleen
Spleen - immunology
Spleen - metabolism
Tumor Burden
Tumors
Vascular endothelial growth factor
Xenografts
γ Radiation
title Gamma-radiated immunosuppressed tumor xenograft mice can be a new ideal model in cancer research
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T13%3A33%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gamma-radiated%20immunosuppressed%20tumor%20xenograft%20mice%20can%20be%20a%20new%20ideal%20model%20in%20cancer%20research&rft.jtitle=Scientific%20reports&rft.au=Khodayari,%20Hamid&rft.date=2021-01-08&rft.volume=11&rft.issue=1&rft.spage=256&rft.epage=256&rft.pages=256-256&rft.eissn=2045-2322&rft_id=info:doi/10.1038/s41598-020-80428-5&rft_dat=%3Cproquest_pubme%3E2476252912%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2476252912&rft_id=info:pmid/33420261&rfr_iscdi=true